2020 Sloan Kettering Management of Cancer Treatment-Related Adverse Events Symposium

2020    The annual 2020 Sloan Kettering Management of Treatment-Related Adverse Events Symposium will be held from Friday, October 23 - Saturday, October 24. The course will be a virtual event this year instead of being held at its past location, Rockefeller Research Laboratories, New York, NY.

The course is directed by MASCC member Mario E. Lacouture, MD, who is the Director of the Oncodermatology Program at Memorial Sloan Kettering Cancer Center.



By registering for the live virtual course, participants will be able to view presentations, hear live audio, and interact online.

All sessions presented live on October 23-24, 2020 will be recorded and made available to attendees for viewing after the course. CME and ABIM MOC credit will be offered for this course and a certificate will be available after a post-course evaluation is complete.  

Symposium Focus 

Systemic anticancer therapies (cytotoxic chemotherapies, targeted therapies, immunotherapies) have resulted in remarkable improvements in patient survival. Despite this remarkable success, most patients will develop toxicities of various organ systems, which may impact overall health and activities of daily living, resulting in inconsistent antineoplastic therapy, all of which may affect clinical outcome. Therefore, prevention and management of untoward events is critical for the maintenance of quality of life and the optimization of anticancer therapies.

2020 Symposium Highlights

  • Therapy-related adverse events will affect most cancer patients, resulting in increased cost, inconsistent dosing, and decreased quality of life.
  • With increased survival and patients living longer on therapy, adverse events affecting quality of life and clinical outcome command attention.
  • Lectures focused on immune-related adverse events will describe the clinical presentation, diagnosis, and management strategies for the oncology healthcare provider.
  • Up-to-date information will be presented on adverse event mechanisms and management from specialists in the most affected organ systems.
  • Practical strategies to identify patients at high risk will be highlighted, with strategies to direct patients towards the most efficient therapies based on healthcare providers.
  • New strategies to monitor and manage symptoms of patients on active anticancer treatment will be discussed including patient-reported outcomes and teleoncology visits. 

The target audience for this symposium includes MDs, PAs, NPs, RNs, pharmacists, and other healthcare professionals treating cancer patients and their associated symptoms. 

This course is endorsed by the Multinational Association of Supportive Care in Cancer. 
For details on the symposium and to register, please click here. 

Share this post: